Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Chongqing Zhifei Biological Products Co., Ltd.
  6. Summary
    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

(300122)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
05/11/2021 05/12/2021 05/13/2021 05/14/2021 05/17/2021 Date
209.82 210.01 208.8 216 223.05 Last
11373820 12540240 13628840 17405900 16264800 Volume
-2.40% +0.09% -0.58% +3.45% +3.26% Change
Financials
Sales 2021 26 117 M 4 056 M 4 056 M
Net income 2021 7 311 M 1 135 M 1 135 M
Net cash position 2021 7 659 M 1 189 M 1 189 M
P/E ratio 2021 48,8x
Yield 2021 0,52%
Sales 2022 31 683 M 4 920 M 4 920 M
Net income 2022 9 005 M 1 398 M 1 398 M
Net cash position 2022 21 784 M 3 383 M 3 383 M
P/E ratio 2022 39,6x
Yield 2022 0,71%
Capitalization 357 B 55 426 M 55 424 M
EV / Sales 2021 13,4x
EV / Sales 2022 10,6x
Nbr of Employees 3 380
Free-Float 14,7%
More Financials
Company
Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus,... 
Sector
Pharmaceuticals
Calendar
06/09 | 10:00pmShareholder meeting
More about the company
Notations Surperformance© of Chongqing Zhifei Biological Products Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
05/06Shares of China vaccine makers slump on U.S. waiver support
RE
04/19CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China trials mixing of CanSinoBIO's and Z..
RE
03/15CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China IMCAS's COVID-19 vaccine obtained e..
RE
02/02Sinopharm's COVID-19 vaccine remained active against S.Africa variant, effect..
RE
2020China's CAS COVID-19 vaccine induces immune response in mid-stage tests
RE
2020MY E G SERVICES  : MyEG Services Partners With Anhui Zhifei Longcom for Covid-19..
MT
2020Hong Kong stocks end higher as investors bet on vaccine progress
RE
2020China stocks end lower after U.S. House clears delisting bill
RE
2020China stocks falter as U.S. House clears delisting bill
RE
2020FACTBOX : The race for a coronavirus vaccine
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China's Zhifei starts Phase II trial of C..
RE
2020CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Chinese firm gets approval to begin human..
RE
2020NEW CHINESE BILLIONAIRES OUTPACE U.S : Hurun
RE
More news
News in other languages on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
05/06MÄRKTE ASIEN/Tokio sehr fest - Chin. Impfstoffhersteller stürzen ab
05/06MÄRKTE ASIEN/Japan sehr fest - Konflikt mit China belastet Sydney
04/19CHINA PRUEBA MEZCLAR VACUNAS COVID-1 : datos
2020En Chine, 182 nouveaux milliardaires en un an
More news
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 219,11 CNY
Last Close Price 223,05 CNY
Spread / Highest target 13,1%
Spread / Average Target -1,77%
Spread / Lowest Target -21,5%
EPS Revisions
Managers and Directors
NameTitle
Ren Sheng Jiang Chairman & General Manager
Zhen Jing Li Chief Financial Officer & Director
Yu Qin Wu Chairman-Supervisory Board
Xin Rong Zhang Independent Director
Bao Kui Liu Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.50.80%53 688
CSL LIMITED-2.33%98 249
WUXI BIOLOGICS (CAYMAN) INC.4.96%57 290
SAMSUNG BIOLOGICS CO.,LTD.14.77%55 625
BIOGEN INC.14.44%42 187
ALEXION PHARMACEUTICALS, INC.11.04%38 345